Lancet Respiratory Medicine, The, ISSN 2213-2600, 2015, Volume 3, Issue 9, pp. 684 - 691
Summary Background Lung delivery of plasmid DNA encoding the CFTR gene complexed with a cationic liposome is a potential treatment option for patients with...
Pulmonary/Respiratory | DNA/LIPOSOMES | EFFICACY | SAFETY | RESPIRATORY SYSTEM | DNA | COMPLEXES | MUTATION | LUNGS | NASAL EPITHELIUM | AZITHROMYCIN | AEROSOL DELIVERY | CRITICAL CARE MEDICINE | Double-Blind Method | Forced Expiratory Volume - drug effects | Cystic Fibrosis - physiopathology | Humans | Administration, Inhalation | Male | United Kingdom | Young Adult | Cystic Fibrosis - genetics | Adolescent | Cystic Fibrosis Transmembrane Conductance Regulator - administration & dosage | Adult | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Female | Liposomes | Mutation | Child | Cystic Fibrosis - drug therapy | Nebulizers and Vaporizers | Plasmids - administration & dosage | Genetic Therapy - methods
Pulmonary/Respiratory | DNA/LIPOSOMES | EFFICACY | SAFETY | RESPIRATORY SYSTEM | DNA | COMPLEXES | MUTATION | LUNGS | NASAL EPITHELIUM | AZITHROMYCIN | AEROSOL DELIVERY | CRITICAL CARE MEDICINE | Double-Blind Method | Forced Expiratory Volume - drug effects | Cystic Fibrosis - physiopathology | Humans | Administration, Inhalation | Male | United Kingdom | Young Adult | Cystic Fibrosis - genetics | Adolescent | Cystic Fibrosis Transmembrane Conductance Regulator - administration & dosage | Adult | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Female | Liposomes | Mutation | Child | Cystic Fibrosis - drug therapy | Nebulizers and Vaporizers | Plasmids - administration & dosage | Genetic Therapy - methods
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 7, pp. 1606 - 1620
Purpose To provide an initial assessment of the safety of a recombinant adeno-associated virus vector expressing RPE65 (rAAV2-CB-hRPE65) in adults and children...
Ophthalmology | CANINE MODEL | VISION | ELECTRORETINOGRAPHY | SAFETY | ROD | TRANSLUCENT | OPHTHALMOLOGY | RPE65 MUTATIONS | HUMAN CONE | PHOTORECEPTORS | DEGENERATION | Electroretinography | Dependovirus - genetics | Visual Fields - physiology | Leber Congenital Amaurosis - physiopathology | Humans | Male | Retinal Degeneration - etiology | Leber Congenital Amaurosis - genetics | Young Adult | cis-trans-Isomerases - genetics | Retinal Degeneration - therapy | Quality of Life | Adult | Female | Genetic Vectors | Child | Leber Congenital Amaurosis - therapy | Visual Acuity - physiology | Injections, Intraocular | Genetic Therapy - methods | Prevention | Care and treatment | Genetic disorders | Genetic vectors | Analysis | Blindness | Retinal degeneration | Gene therapy
Ophthalmology | CANINE MODEL | VISION | ELECTRORETINOGRAPHY | SAFETY | ROD | TRANSLUCENT | OPHTHALMOLOGY | RPE65 MUTATIONS | HUMAN CONE | PHOTORECEPTORS | DEGENERATION | Electroretinography | Dependovirus - genetics | Visual Fields - physiology | Leber Congenital Amaurosis - physiopathology | Humans | Male | Retinal Degeneration - etiology | Leber Congenital Amaurosis - genetics | Young Adult | cis-trans-Isomerases - genetics | Retinal Degeneration - therapy | Quality of Life | Adult | Female | Genetic Vectors | Child | Leber Congenital Amaurosis - therapy | Visual Acuity - physiology | Injections, Intraocular | Genetic Therapy - methods | Prevention | Care and treatment | Genetic disorders | Genetic vectors | Analysis | Blindness | Retinal degeneration | Gene therapy
Journal Article
Human Gene Therapy Clinical Development, ISSN 2324-8637, 03/2017, Volume 28, Issue 1, pp. 39 - 50
Vectors based on adeno-associated virus serotype 8 (AAV8) have been evaluated in several clinical trials of gene therapy for hemophilia B with encouraging...
toxicology | gene therapy | low density lipoprotein receptor | LDLR | AAV | familial hypercholesterolemia | MEDICINE, RESEARCH & EXPERIMENTAL | EFFICACY | SAFETY | MEDIATED GENE-TRANSFER | DEFICIENCY | RESPONSES | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | HEMOPHILIA-B | LIVER | DENSITY-LIPOPROTEIN RECEPTOR | Dependovirus - genetics | Genetic Therapy | Hyperlipoproteinemia Type II - therapy | Receptors, LDL - genetics | Liver - pathology | Genetic Vectors - administration & dosage | Cholesterol - blood | Humans | Liver - metabolism | APOBEC-1 Deaminase - genetics | Male | Macaca mulatta | Mutation - genetics | APOBEC-1 Deaminase - deficiency | Animals | Receptors, LDL - deficiency | Genetic Vectors - toxicity | Female | Disease Models, Animal | Hyperlipoproteinemia Type II - genetics
toxicology | gene therapy | low density lipoprotein receptor | LDLR | AAV | familial hypercholesterolemia | MEDICINE, RESEARCH & EXPERIMENTAL | EFFICACY | SAFETY | MEDIATED GENE-TRANSFER | DEFICIENCY | RESPONSES | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | HEMOPHILIA-B | LIVER | DENSITY-LIPOPROTEIN RECEPTOR | Dependovirus - genetics | Genetic Therapy | Hyperlipoproteinemia Type II - therapy | Receptors, LDL - genetics | Liver - pathology | Genetic Vectors - administration & dosage | Cholesterol - blood | Humans | Liver - metabolism | APOBEC-1 Deaminase - genetics | Male | Macaca mulatta | Mutation - genetics | APOBEC-1 Deaminase - deficiency | Animals | Receptors, LDL - deficiency | Genetic Vectors - toxicity | Female | Disease Models, Animal | Hyperlipoproteinemia Type II - genetics
Journal Article
Human Gene Therapy Clinical Development, ISSN 2324-8637, 03/2017, Volume 28, Issue 1, pp. 28 - 38
The homozygous form of familial hypercholesterolemia (HoFH) is an excellent model for developing in vivo gene therapy in humans. The success of orthotropic...
gene therapy | low density lipoprotein receptor | HoFH | LDLR | AAV | familial hypercholesterolemia | MEDICINE, RESEARCH & EXPERIMENTAL | ATHEROSCLEROSIS | PORTACAVAL-SHUNT | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CHOLESTEROL LEVELS | GENE-THERAPY | MICE | VECTORS | DENSITY-LIPOPROTEIN RECEPTOR | Dependovirus - genetics | Genetic Therapy | Hyperlipoproteinemia Type II - therapy | Receptors, LDL - genetics | Liver - pathology | Genetic Vectors - administration & dosage | Cholesterol - blood | Humans | Liver - metabolism | Mice, Inbred C57BL | APOBEC-1 Deaminase - genetics | Male | Mice, Knockout | APOBEC-1 Deaminase - deficiency | Homozygote | Animals | Receptors, LDL - deficiency | Genetic Vectors - toxicity | Female | Mice | Disease Models, Animal | Hyperlipoproteinemia Type II - genetics
gene therapy | low density lipoprotein receptor | HoFH | LDLR | AAV | familial hypercholesterolemia | MEDICINE, RESEARCH & EXPERIMENTAL | ATHEROSCLEROSIS | PORTACAVAL-SHUNT | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CHOLESTEROL LEVELS | GENE-THERAPY | MICE | VECTORS | DENSITY-LIPOPROTEIN RECEPTOR | Dependovirus - genetics | Genetic Therapy | Hyperlipoproteinemia Type II - therapy | Receptors, LDL - genetics | Liver - pathology | Genetic Vectors - administration & dosage | Cholesterol - blood | Humans | Liver - metabolism | Mice, Inbred C57BL | APOBEC-1 Deaminase - genetics | Male | Mice, Knockout | APOBEC-1 Deaminase - deficiency | Homozygote | Animals | Receptors, LDL - deficiency | Genetic Vectors - toxicity | Female | Mice | Disease Models, Animal | Hyperlipoproteinemia Type II - genetics
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.